Evidence map›Paper›PMID 38125023›Full record

ArticleiScience2023

Greta Volpedo, Timur Oljuskin, Blake Cox, Yulian Mercado, Candice Askwith, Nazli Azodi, Matthew Bernier, Hira L Nakhasi, Sreenivas Gannavaram, Abhay R Satoskar

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Virulence · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Greta VolpedoDepartment of Microbiology, The Ohio State University, Columbus, OH 43210, USA.
Timur OljuskinAnimal Parasitic Disease Lab, Agricultural Research Service, USDA, Beltsville, MD, USA.
Blake CoxDepartment of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH 43210, USA.
Yulian MercadoDepartment of Pathology, Wexner Medical Center, The Ohio State University, Columbus, OH 43210, USA.
Candice AskwithDepartment of Neuroscience, The Ohio State University, Columbus, OH 43210, USA.
Nazli AzodiDivision of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, USA.
Matthew BernierMass Spectrometry and Proteomics Facility, The Ohio State University, Columbus, OH 43210, USA.
Hira L NakhasiDivision of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, USA.
Sreenivas GannavaramDivision of Emerging and Transfusion Transmitted Diseases, CBER, FDA, Silver Spring, MD, USA.
Abhay R SatoskarDepartment of Microbiology, The Ohio State University, Columbus, OH 43210, USA.
The Ohio State University · USThe Ohio State University Wexner Medical Center · USAgricultural Research Service · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous leishmaniasis (CL) is characterized by extensive skin lesions, which are usually painless despite being associated with extensive inflammation. The molecular mechanisms responsible for this analgesia have not been identified. Through untargeted metabolomics, we found enriched anti-nociceptive metabolic pathways in

Indexed as

ImmunologyMetabolomicsParasitology

Identifiers

PMID38125023
PMCPMC10730346
OpenAlexW4388915081

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.